Bright Minds Biosciences (DRUG) Operating Leases (2022 - 2026)
Bright Minds Biosciences (DRUG) reported Operating Leases of -$56,866 for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with $53,436 a year earlier.
Powered by 
Analysis
Bright Minds Biosciences (DRUG) Operating Leases (2022 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Bright Minds Biosciences posted Operating Leases of $29,513, up 1.4% from FY2024.
- Operating Leases has a three-year compound annual growth rate of -19.4% (FY2022 to FY2025).
- By fiscal year, Operating Leases came in at $29,096 in FY2024, -$63,868 in FY2023 and $56,386 in FY2022.
- The fiscal Q3 2026 figure ranks as the lowest quarterly Operating Leases since fiscal Q4 2023.
- Year over year, Operating Leases gained in four of the last five quarters, with growth averaging 81.6%.
- The high point for year-over-year Operating Leases in five years was fiscal Q1 2025 (growth of 388.5%); the low point was fiscal Q1 2026 (a decline of 84.8%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at -$38,132 (Q2 2026), $12,007 (Q1 2026) and $29,973 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Bright Minds Biosciences | 380.42 Mn | 380.42 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -56,866.02 |
| Mar 31, 2026 | -38,132.35 |
| Dec 31, 2025 | 12,006.89 |
| Sep 30, 2025 | 29,972.97 |
| Jun 30, 2025 | 53,435.59 |
| Mar 31, 2025 | 61,918.24 |
| Dec 31, 2024 | 78,792.08 |
| Sep 30, 2024 | 29,011.32 |
| Jun 30, 2024 | 48,160.96 |
| Mar 31, 2024 | 32,589.16 |
| Dec 31, 2023 | 16,128.20 |
| Sep 30, 2023 | -64,233.56 |
| Jun 30, 2023 | 47,992.62 |
| Mar 31, 2023 | 31,790.67 |
| Dec 31, 2022 | 40,197.46 |
| Sep 30, 2022 | 5,491.44 |
API Access
Bright Minds Biosciences Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=DRUG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "DRUG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=DRUG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();